{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:44:11Z","timestamp":1790685851333,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02610-9","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T10:03:04Z","timestamp":1679565784000},"page":"2129-2136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study"],"prefix":"10.1007","volume":"315","author":[{"given":"Mika","family":"Yamanaka-Takaichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishab","family":"Revankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Y.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"2610_CR1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C et al (2019) North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol 81:76\u201390","journal-title":"J Am Acad Dermatol"},{"key":"2610_CR2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijwd.2019.11.004","volume":"6","author":"E Nesbitt","year":"2020","unstructured":"Nesbitt E, Clements S, Driscoll M (2020) A concise clinician\u2019s guide to therapy for hidradenitis suppurativa. Int J Women\u2019s Dermatol 6:80\u201384","journal-title":"Int J Women's Dermatol"},{"key":"2610_CR3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijwd.2021.08.005","volume":"7","author":"R Revankar","year":"2021","unstructured":"Revankar R, Murrell DF, Murase JE (2021) Shedding light on the impact of hidradenitis suppurativa on women and their families: a focus of the International Journal of Women\u2019s Dermatology. Int J Women\u2019s Dermatol 7:661\u2013663","journal-title":"Int J Women's Dermatol"},{"key":"2610_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijwd.2017.10.007","volume":"4","author":"A Alavi","year":"2018","unstructured":"Alavi A, Farzanfar D, Rogalska T, Lowes MA, Chavoshi S (2018) Quality of life and sexual health in patients with hidradenitis suppurativa. Int J Women\u2019s Dermatol 4:74\u201379","journal-title":"Int J Women's Dermatol"},{"key":"2610_CR5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamadermatol.2019.0759","volume":"155","author":"MO Machado","year":"2019","unstructured":"Machado MO, Stergiopoulos V, Maes M, Kurdyak PA, Lin PY, Wang LJ et al (2019) Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis. JAMA Dermatol 155:939\u2013945","journal-title":"JAMA Dermatol"},{"key":"2610_CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaad.2021.06.843","volume":"86","author":"S Wright","year":"2022","unstructured":"Wright S, Strunk A, Garg A (2022) Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa. J Am Acad Dermatol 86:55\u201360","journal-title":"J Am Acad Dermatol"},{"key":"2610_CR7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2133.1995.tb02624.x","volume":"133","author":"RL Attanoos","year":"1995","unstructured":"Attanoos RL, Appleton MA, Douglas-Jones AG (1995) The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 133:254\u2013258","journal-title":"Br J Dermatol"},{"key":"2610_CR8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijwd.2019.06.026","volume":"5","author":"A Cartron","year":"2019","unstructured":"Cartron A, Driscoll MS (2019) Comorbidities of hidradenitis suppurativa: a review of the literature. Int J Women\u2019s Dermatol 5:330\u2013334","journal-title":"Int J Women's Dermatol"},{"key":"2610_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/derm.2.1.12490","volume":"2","author":"S Fimmel","year":"2010","unstructured":"Fimmel S, Zouboulis CC (2010) Comorbidities of hidradenitis suppurativa (acne inversa). Dermato-endocrinology 2:9\u201316","journal-title":"Dermato-endocrinology"},{"key":"2610_CR10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","volume":"86","author":"A Garg","year":"2022","unstructured":"Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R et al (2022) Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol 86:1092\u20131101","journal-title":"J Am Acad Dermatol"},{"key":"2610_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13555-020-00354-2","volume":"10","author":"T Tzellos","year":"2020","unstructured":"Tzellos T, Zouboulis CC (2020) Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice. Dermatol Ther 10:63\u201371","journal-title":"Dermatol Ther"},{"key":"2610_CR12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.surg.2014.04.033","volume":"156","author":"C Cannistra","year":"2014","unstructured":"Cannistra C, Finocchi V, Trivisonno A, Tambasco D (2014) New perspectives in the treatment of hidradenitis suppurativa (surgery and brewer\u2019s yeast-exclusion diet): some clarifications. Surgery 156:736","journal-title":"Surgery"},{"key":"2610_CR13","volume":"33","author":"JM Fernandez","year":"2020","unstructured":"Fernandez JM, Marr KD, Hendricks AJ, Price KN, Ludwig CM, Maarouf M et al (2020) Alleviating and exacerbating foods in hidradenitis suppurativa. Dermatol Ther 33:e14246","journal-title":"Dermatol Ther"},{"key":"2610_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000503063","volume":"236","author":"A Dempsey","year":"2020","unstructured":"Dempsey A, Butt M, Kirby JS (2020) Prevalence and impact of dietary avoidance among individuals with hidradenitis suppurativa. Dermatology (Basel, Switzerland) 236:289\u2013295","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"2610_CR15","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jaad.2020.05.148","volume":"84","author":"W Li","year":"2021","unstructured":"Li W, Ma JE, Chan AA, Lee DJ, Smogorzewski J (2021) Hidradenitis suppurativa through the lens of YouTube: a cross-sectional analysis. J Am Acad Dermatol 84:1398\u20131399","journal-title":"J Am Acad Dermatol"},{"key":"2610_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/jbcr\/irac183","volume":"44","author":"LV Yesantharao","year":"2022","unstructured":"Yesantharao LV, Suresh R, Lerman SF, Cox C, Caffrey J (2022) Hidradenitis suppurativa reddit support group: finding new meaning in social media during the COVID-19 pandemic. J Burn Care Res 44:373\u2013380","journal-title":"J Burn Care Res"},{"key":"2610_CR17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/ced.15017","volume":"47","author":"D Lukac","year":"2022","unstructured":"Lukac D, Pagani K, Yi JZ, McGee JS (2022) Consulting \u201cDr YouTube\u201d: a content analysis of YouTube(\u00ae) videos related to hidradenitis suppurativa treatments. Clin Exp Dermatol 47:606\u2013608","journal-title":"Clin Exp Dermatol"},{"key":"2610_CR18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12874-016-0165-8","volume":"16","author":"BH Eubank","year":"2016","unstructured":"Eubank BH, Mohtadi NG, Lafave MR, Wiley JP, Bois AJ, Boorman RS et al (2016) Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. BMC Med Res Methodol 16:56","journal-title":"BMC Med Res Methodol"},{"key":"2610_CR19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/1203475417716117","volume":"21","author":"A Alavi","year":"2017","unstructured":"Alavi A, Lynde C, Alhusayen R, Bourcier M, Delorme I, George R et al (2017) Approach to the management of patients with hidradenitis suppurativa: a consensus document. J Cutan Med Surg 21:513\u2013524","journal-title":"J Cutan Med Surg"},{"key":"2610_CR20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.12968\/bjtr.1996.3.12.14731","volume":"3","author":"A Walker","year":"1996","unstructured":"Walker A, Selfe J (1996) The Delphi method: a useful tool for the allied health researcher. Br J Ther Rehabil 3:677\u2013681","journal-title":"Br J Ther Rehabil"},{"key":"2610_CR21","unstructured":"Lilja KK, Laakso K , Palom\u00e4ki J (2011) Using the Delphi method. In: 2011 Proceedings of PICMET'11: Technology Management in the Energy Smart World (PICMET): IEEE, pp 1\u201310"},{"key":"2610_CR22","unstructured":"Clair JS (2005) Advances in patient safety: a new model of tracheostomy care: closing the research\u2013practice gap. In: Henriksen K, Battles JB, Marks ES, Lewin DI (eds) Advances in patient safety: from research to implementation (volume 3: implementation issues). Agency for Healthcare Research and Quality (US), Rockville"},{"key":"2610_CR23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaad.2020.04.092","volume":"83","author":"E Molinelli","year":"2020","unstructured":"Molinelli E, Brisigotti V, Campanati A, Sapigni C, Giacchetti A, Cota C et al (2020) Efficacy of oral zinc and nicotinamide as maintenance therapy for mild\/moderate hidradenitis suppurativa: a controlled retrospective clinical study. J Am Acad Dermatol 83:665\u2013667","journal-title":"J Am Acad Dermatol"},{"key":"2610_CR24","first-page":"1347","volume":"29","author":"A Guillet","year":"2015","unstructured":"Guillet A, Brocard A, Bach Ngohou K, Graveline N, Leloup AG, Ali D et al (2015) Verneuil\u2019s disease, innate immunity and vitamin D: a pilot study. JEADV 29:1347\u20131353","journal-title":"JEADV"},{"key":"2610_CR25","volume":"8","author":"JW Frew","year":"2021","unstructured":"Frew JW, Singh N, Jiang CS, Vaughan R, Krueger JG (2021) The impact of body mass index upon the efficacy of adalimumab in hidradenitis suppurativa. Front Med 8:603281","journal-title":"Front Med"},{"key":"2610_CR26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/ijd.15459","volume":"60","author":"AR J\u00f8rgensen","year":"2021","unstructured":"J\u00f8rgensen AR, Yao Y, Thomsen SF, Ring HC (2021) Treatment of hidradenitis suppurativa with tetracycline, doxycycline, or lymecycline: a prospective study. Int J Dermatol 60:785\u2013791","journal-title":"Int J Dermatol"},{"key":"2610_CR27","volume":"34","author":"M Iannone","year":"2021","unstructured":"Iannone M, Janowska A, Bartolomei G, Puntoni M, Oranges T, Romanelli M et al (2021) Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy. Dermatol Ther 34:e14919","journal-title":"Dermatol Ther"},{"key":"2610_CR28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/12034754211039993","volume":"26","author":"S Garcovich","year":"2022","unstructured":"Garcovich S, Fania L, Caposiena D, Giovanardi G, Chiricozzi A, De Simone C et al (2022) Pediatric hidradenitis suppurativa: a cross-sectional study on clinical features and treatment approaches. J Cutan Med Surg 26:127\u2013134","journal-title":"J Cutan Med Surg"},{"key":"2610_CR29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000447716","volume":"2","author":"G Fabbrocini","year":"2016","unstructured":"Fabbrocini G, De Vita V, Donnarumma M, Russo G, Monfrecola G (2016) South Italy: a privileged perspective to understand the relationship between hidradenitis suppurativa and overweight\/obesity. Skin Append Disord 2:52\u201356","journal-title":"Skin Append Disord"},{"key":"2610_CR30","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1111\/ced.13861","volume":"44","author":"L Bianchi","year":"2019","unstructured":"Bianchi L, Caposiena Caro RD, Ganzetti G, Molinelli E, Dini V, Oranges T et al (2019) Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort. Clin Exp Dermatol 44:e177\u2013e180","journal-title":"Clin Exp Dermatol"},{"key":"2610_CR31","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","volume":"71","author":"AM Schrader","year":"2014","unstructured":"Schrader AM, Deckers IE, van der Zee HH, Boer J, Prens EP (2014) Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol 71:460\u2013467","journal-title":"J Am Acad Dermatol"},{"key":"2610_CR32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00403-020-02053-6","volume":"312","author":"PT Riis","year":"2020","unstructured":"Riis PT, Saunte DM, Sigsgaard V, Villani AP, Guillem P, Pascual JC et al (2020) Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients. Arch Dermatol Res 312:715\u2013724","journal-title":"Arch Dermatol Res"},{"key":"2610_CR33","first-page":"307","volume":"32","author":"P Theut Riis","year":"2018","unstructured":"Theut Riis P, Saunte DM, Benhadou F, Del Marmol V, Guillem P, El-Domyati M et al (2018) Low and high body mass index in hidradenitis suppurativa patients-different subtypes? JEADV 32:307\u2013312","journal-title":"JEADV"},{"key":"2610_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200683","volume":"13","author":"M Calao","year":"2018","unstructured":"Calao M, Wilson JL, Spelman L, Billot L, Rubel D, Watts AD et al (2018) Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: a population-based cross-sectional study. PLoS ONE 13:e0200683","journal-title":"PLoS ONE"},{"key":"2610_CR35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/bjd.19713","volume":"185","author":"S Wright","year":"2021","unstructured":"Wright S, Strunk A, Garg A (2021) Trends in body mass index before and after diagnosis of hidradenitis suppurativa. Br J Dermatol 185:74\u201379","journal-title":"Br J Dermatol"},{"key":"2610_CR36","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamadermatol.2020.1047","volume":"156","author":"AR J\u00f8rgensen","year":"2020","unstructured":"J\u00f8rgensen AR, Aarestrup J, Baker JL, Thomsen SF (2020) Association of birth weight, childhood body mass index, and height with risk of hidradenitis suppurativa. JAMA Dermatol 156:746\u2013753","journal-title":"JAMA Dermatol"},{"key":"2610_CR37","first-page":"717","volume":"36","author":"R Kjaersgaard Andersen","year":"2022","unstructured":"Kjaersgaard Andersen R, Loft IC, Hansen T, Hjalgrim H, Rostgaard K, Banasik K et al (2022) Incidence and remission rates of self-reported hidradenitis suppurative\u2014a prospective cohort study conducted in Danish blood donors. JEADV 36:717\u2013725","journal-title":"JEADV"},{"key":"2610_CR38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/ijd.13985","volume":"57","author":"C Dessinioti","year":"2018","unstructured":"Dessinioti C, Tzanetakou V, Zisimou C, Kontochristopoulos G, Antoniou C (2018) A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa. Int J Dermatol 57:687\u2013691","journal-title":"Int J Dermatol"},{"key":"2610_CR39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2340\/00015555-1800","volume":"94","author":"CB Kromann","year":"2014","unstructured":"Kromann CB, Ibler KS, Kristiansen VB, Jemec GB (2014) The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol 94:553\u2013557","journal-title":"Acta Derm Venereol"},{"key":"2610_CR40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/ced.12269","volume":"39","author":"CL Thomas","year":"2014","unstructured":"Thomas CL, Gordon KD, Mortimer PS (2014) Rapid resolution of hidradenitis suppurativa after bariatric surgical intervention. Clin Exp Dermatol 39:315\u2013317 (quiz 7\u20138)","journal-title":"Clin Exp Dermatol"},{"key":"2610_CR41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jdcr.2017.06.008","volume":"3","author":"C Gallagher","year":"2017","unstructured":"Gallagher C, Kirthi S, Burke T, O\u2019Shea D, Tobin AM (2017) Remission of hidradenitis suppurativa after bariatric surgery. JAAD Case Rep 3:436\u2013437","journal-title":"JAAD Case Rep"},{"key":"2610_CR42","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/bjd.15233","volume":"177","author":"L Jennings","year":"2017","unstructured":"Jennings L, Nestor L, Molloy O, Hughes R, Moriarty B, Kirby B (2017) The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide. Br J Dermatol 177:858\u2013859","journal-title":"Br J Dermatol"},{"key":"2610_CR43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00403-021-02233-y","volume":"314","author":"PC Macklis","year":"2022","unstructured":"Macklis PC, Tyler K, Kaffenberger J, Kwatra S, Kaffenberger BH (2022) Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients. Arch Dermatol Res 314:293\u2013300","journal-title":"Arch Dermatol Res"},{"key":"2610_CR44","first-page":"895","volume":"30","author":"J Boer","year":"2016","unstructured":"Boer J (2016) Resolution of hidradenitis suppurativa after weight loss by dietary measures, especially on frictional locations. JEADV 30:895\u2013896","journal-title":"JEADV"},{"key":"2610_CR45","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/ijd.16228","volume":"61","author":"O Sokumbi","year":"2022","unstructured":"Sokumbi O, Hodge DO, Ederaine SA, Alavi A, Alikhan A (2022) Comorbid diseases of hidradenitis suppurativa: a 15-year population-based study in Olmsted County, Minnesota, USA. Int J Dermatol 61:1372\u20131379","journal-title":"Int J Dermatol"},{"key":"2610_CR46","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.3390\/ijms23084312","volume":"23","author":"K Ikeda","year":"2022","unstructured":"Ikeda K, Morizane S, Akagi T, Hiramatsu-Asano S, Tachibana K, Yahagi A et al (2022) Obesity and dyslipidemia synergistically exacerbate psoriatic skin inflammation. Int J Mol Sci 23:4312","journal-title":"Int J Mol Sci"},{"key":"2610_CR47","first-page":"462","volume":"36","author":"Z Dajnoki","year":"2022","unstructured":"Dajnoki Z, Somogyi O, Medgyesi B, Jenei A, Szab\u00f3 L, G\u00e1sp\u00e1r K et al (2022) Primary alterations during the development of hidradenitis suppurativa. JEADV 36:462\u2013471","journal-title":"JEADV"},{"key":"2610_CR48","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jaad.2019.10.044","volume":"82","author":"P Acharya","year":"2020","unstructured":"Acharya P, Mathur M (2020) Hidradenitis suppurativa and smoking: a systematic review and meta-analysis. J Am Acad Dermatol 82:1006\u20131011","journal-title":"J Am Acad Dermatol"},{"key":"2610_CR49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2016.07.041","volume":"76","author":"G Denny","year":"2017","unstructured":"Denny G, Anadkat MJ (2017) The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: an institutional retrospective cohort study. J Am Acad Dermatol 76:54\u201359","journal-title":"J Am Acad Dermatol"},{"key":"2610_CR50","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.3390\/ijms22105204","volume":"22","author":"Y Sawada","year":"2021","unstructured":"Sawada Y, Saito-Sasaki N, Mashima E, Nakamura M (2021) Daily lifestyle and inflammatory skin diseases. Int J Mol Sci 22:5204","journal-title":"Int J Mol Sci"},{"key":"2610_CR51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104154","volume":"82","author":"SC Larsson","year":"2022","unstructured":"Larsson SC, Burgess S (2022) Appraising the causal role of smoking in multiple diseases: a systematic review and meta-analysis of Mendelian randomization studies. EBioMedicine 82:104154","journal-title":"EBioMedicine"},{"key":"2610_CR52","first-page":"9","volume":"28","author":"Z Bukvi\u0107 Mokos","year":"2020","unstructured":"Bukvi\u0107 Mokos Z, Mi\u0161e J, Bali\u0107 A, Marinovi\u0107 B (2020) Understanding the relationship between smoking and hidradenitis suppurativa. ADC 28:9\u201313","journal-title":"ADC"},{"key":"2610_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/nu11010057","volume":"11","author":"L Barrea","year":"2018","unstructured":"Barrea L, Fabbrocini G, Annunziata G, Muscogiuri G, Donnarumma M, Marasca C et al (2018) Role of nutrition and adherence to the mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: evaluation of nutritional status and its association with severity of disease. Nutrients 11:57","journal-title":"Nutrients"},{"key":"2610_CR54","first-page":"jphr-2021","volume":"11","author":"F Velluzzi","year":"2021","unstructured":"Velluzzi F, Anedda J, Pisanu S, Dell\u2019Antonia M, Deledda A, Boi A et al (2021) Mediterranean diet, lifestyle and quality of life in Sardinian patients affected with Hidradenitis suppurativa. J Public Health Res 11:jphr-2021","journal-title":"J Public Health Res"},{"key":"2610_CR55","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/nu14030551","volume":"14","author":"I Lorite-Fuentes","year":"2022","unstructured":"Lorite-Fuentes I, Montero-Vilchez T, Arias-Santiago S, Molina-Leyva A (2022) Potential benefits of the mediterranean diet and physical activity in patients with hidradenitis suppurativa: a cross-sectional study in a Spanish population. Nutrients 14:551","journal-title":"Nutrients"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02610-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02610-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02610-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T14:10:40Z","timestamp":1690207840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02610-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["2610"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02610-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AA is on the Board of Directors for the Hidradenitis Suppurativa Foundation and served as a consultant for AbbVie, Boehringer Ingelheim, Infla Rx, Janssen, Novartis and UCB and investigator for Boehringer Ingelheim, Processa. JLH is on the Board of Directors for the Hidradenitis Suppurativa Foundation, has served as a consultant for Boehringer Ingelheim, Novartis, and UCB, and has served as a consultant and speaker for AbbVie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval"}}]}}